Health & Biotech
Check out the latest news, insights and unique analysis brought to you by Stockhead's team of business journalists and industry experts on Imugene.
RELATED STOCKHEAD STORIES
Health & Biotech
Check Up: Rhythm leads ASX health stocks on progress on replacement for poo tests
News
ASX Small Cap Lunch Wrap: Who’s on target for their best month in 32 years?
News
Last Orders: What you might have missed on the ASX today
News
10 at 10: These ASX stocks have conquered the greatest depths this morning
Health & Biotech
Pharmaxis to get $14m payday after its cystic fibrosis treatment Bronchitol approved by FDA
Stockhead TV
ASX small caps leading the fight against cancer
Guides
ASX stocks capital raising guide: Here’s everything you need to know
Health & Biotech
Dr Boreham’s Crucible: Kazia reaches the ‘endgame’
Health & Biotech
Advance Nanotek boss reiterates threat to quit the ASX
Experts
Scopo’s powerplays: It just won’t go down!
News
10 at 10: These ASX stocks are starry-eyed this morning
News
Closing Bell: Today’s biggest small cap movers on the ASX
News
Short & Caught: The ASX small caps investors are shorting right now
Health & Biotech
Selvax cures cancer in dogs, says it’s eyeing an IPO
Health & Biotech
ASX cracks down on coronavirus claims
Health & Biotech
Cancer Wars Part 1: These are the ASX small cap drugmakers that want to conquer cancer
Health & Biotech
